PVRL3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.787400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.062800E-01
Normal-vs-Stage2
2.771200E-01
Normal-vs-Stage3
3.943200E-01
Normal-vs-Stage4
8.562200E-02
Stage1-vs-Stage2
7.799200E-01
Stage1-vs-Stage3
5.920400E-01
Stage1-vs-Stage4
1.352170E-01
Stage2-vs-Stage3
5.569800E-01
Stage2-vs-Stage4
1.452390E-01
Stage3-vs-Stage4
1.151390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.815800E-01
Normal-vs-AfricanAmerican
2.261800E-01
Normal-vs-Asian
4.919200E-01
Caucasian-vs-AfricanAmerican
9.245800E-01
Caucasian-vs-Asian
2.348000E-01
AfricanAmerican-vs-Asian
2.455400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.076400E-01
Normal-vs-Female
2.600200E-01
Male-vs-Female
3.294200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.579600E-01
Normal-vs-Age(41-60Yrs)
2.214800E-01
Normal-vs-Age(61-80Yrs)
2.968400E-01
Normal-vs-Age(81-100Yrs)
6.157200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.754200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.887000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.175200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.125770E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.324100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.587840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.817400E-01
Normal-vs-Daily Drinker
5.005200E-01
Normal-vs-Weekly Drinker
4.500200E-01
Normal-vs-Occasional Drinker
2.042400E-01
Normal-vs-Social Drinker
3.978800E-01
Non Drinker-vs-Daily Drinker
4.562200E-01
Non Drinker-vs-Weekly Drinker
9.666000E-01
Non Drinker-vs-Occasional Drinker
4.104100E-02
Non Drinker-vs-Social Drinker
4.235800E-01
Daily Drinker-vs-Weekly Drinker
5.690400E-01
Daily Drinker-vs-Occasional Drinker
1.918320E-02
Daily Drinker-vs-Social Drinker
2.392800E-01
Weekly Drinker-vs-Occasional Drinker
5.157800E-02
Weekly Drinker-vs-Social Drinker
4.533400E-01
Occasional Drinker-vs-Social Drinker
2.710800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.445760E-01
Normal-vs-Grade 2
1.119020E-01
Normal-vs-Grade 3
1.043620E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.063110E-03
Grade 1-vs-Grade 3
1.508020E-02
Grade 1-vs-Grade 4
1.445760E-01
Grade 2-vs-Grade 3
6.185800E-01
Grade 2-vs-Grade 4
1.119020E-01
Grade 3-vs-Grade 4
1.043620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.375600E-01
Normal-vs-NonDiabetic
2.668400E-01
Diabetic-vs-NonDiabetic
4.436600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.294600E-01
Normal-vs-NoPancreatitis
2.995600E-01
Pancreatitis-vs-NoPancreatitis
1.590030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.394600E-01
Normal-vs-N1
2.527200E-01
N0-vs-N1
8.717600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.373200E-01
Normal-vs-TP53-NonMutant
2.374800E-01
TP53-Mutant-vs-TP53-NonMutant
7.835800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
